-
A phase I trial evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of intravenously administered low-anticoagulant heparin (M6229) in critically ill sepsis patients
van Mourik, N., van Amstel, R. B. E., Slim, M. A., van Vught, L. A., van der Poll, T., Huckriede, J., de Vries, F., de Kimpe, S. J., Crabbé, R., van Leeuwen, S. J. M., Ekhart, P. F., Reutelingsperger, C. P. M., Nicolaes, G. A. F., Vlaar, A. P. J. & Müller, M. C. A., 1 Dec 2025, In: Intensive Care Medicine Experimental. 13, 1, 84.Research output: Contribution to journal › Article › Academic › peer-review
-
High PEEP/low FiO2 ventilation is associated with lower mortality in COVID–19
the PRoVAcT-COVID investigators, 1 Oct 2024, In: Journal of Critical Care. 83, 154854.Research output: Contribution to journal › Article › Academic › peer-review
-
Sepsis: From one-size-fits-all to personalized medicine
van Mourik, N., 14 Jun 2024, 396 p.Research output: PhD thesis › Research HvA, graduation HvA (not in use)
- All publications
